Noninvasive neuromodulation in migraine and cluster headache

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Purpose of review The purpose of this narrative review is to provide an overview of the currently available noninvasive neuromodulation devices for the treatment of migraine and cluster headache. Recent findings Over the last decade, several noninvasive devices have undergone development and clinical trials to evaluate efficacy and safety. Based on this body of work, single-pulse transcranial magnetic stimulation, transcutaneous supraorbital neurostimulation, and noninvasive vagal nerve stimulation devices have been cleared by the United States Food and Drug Administration and are available for clinical use for the treatment of primary headache disorders. Summary Overall, these novel noninvasive devices appear to be safe, well tolerated, and have demonstrated promising results in clinical trials in both migraine and cluster headache. This narrative review will provide a summary and update of the proposed mechanisms of action, evidence, safety, and future directions of various currently available modalities of noninvasive neuromodulation for the treatment of migraine and cluster headache.

Original languageEnglish (US)
Pages (from-to)268-273
Number of pages6
JournalCurrent Opinion in Neurology
Volume31
Issue number3
DOIs
StatePublished - Jun 1 2018

Fingerprint

Cluster Headache
Migraine Disorders
Equipment and Supplies
Clinical Trials
Primary Headache Disorders
Vagus Nerve Stimulation
Safety
Transcranial Magnetic Stimulation
United States Food and Drug Administration
Therapeutics

Keywords

  • cluster headache
  • migraine
  • neuromodulation
  • transcranial magnetic stimulation
  • transcutaneous supraorbital nerve stimulation
  • vagal nerve stimulation

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Noninvasive neuromodulation in migraine and cluster headache. / Starling, Amaal.

In: Current Opinion in Neurology, Vol. 31, No. 3, 01.06.2018, p. 268-273.

Research output: Contribution to journalReview article

@article{968fcdfb3aed4097a75e343eac2d8457,
title = "Noninvasive neuromodulation in migraine and cluster headache",
abstract = "Purpose of review The purpose of this narrative review is to provide an overview of the currently available noninvasive neuromodulation devices for the treatment of migraine and cluster headache. Recent findings Over the last decade, several noninvasive devices have undergone development and clinical trials to evaluate efficacy and safety. Based on this body of work, single-pulse transcranial magnetic stimulation, transcutaneous supraorbital neurostimulation, and noninvasive vagal nerve stimulation devices have been cleared by the United States Food and Drug Administration and are available for clinical use for the treatment of primary headache disorders. Summary Overall, these novel noninvasive devices appear to be safe, well tolerated, and have demonstrated promising results in clinical trials in both migraine and cluster headache. This narrative review will provide a summary and update of the proposed mechanisms of action, evidence, safety, and future directions of various currently available modalities of noninvasive neuromodulation for the treatment of migraine and cluster headache.",
keywords = "cluster headache, migraine, neuromodulation, transcranial magnetic stimulation, transcutaneous supraorbital nerve stimulation, vagal nerve stimulation",
author = "Amaal Starling",
year = "2018",
month = "6",
day = "1",
doi = "10.1097/WCO.0000000000000557",
language = "English (US)",
volume = "31",
pages = "268--273",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Noninvasive neuromodulation in migraine and cluster headache

AU - Starling, Amaal

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Purpose of review The purpose of this narrative review is to provide an overview of the currently available noninvasive neuromodulation devices for the treatment of migraine and cluster headache. Recent findings Over the last decade, several noninvasive devices have undergone development and clinical trials to evaluate efficacy and safety. Based on this body of work, single-pulse transcranial magnetic stimulation, transcutaneous supraorbital neurostimulation, and noninvasive vagal nerve stimulation devices have been cleared by the United States Food and Drug Administration and are available for clinical use for the treatment of primary headache disorders. Summary Overall, these novel noninvasive devices appear to be safe, well tolerated, and have demonstrated promising results in clinical trials in both migraine and cluster headache. This narrative review will provide a summary and update of the proposed mechanisms of action, evidence, safety, and future directions of various currently available modalities of noninvasive neuromodulation for the treatment of migraine and cluster headache.

AB - Purpose of review The purpose of this narrative review is to provide an overview of the currently available noninvasive neuromodulation devices for the treatment of migraine and cluster headache. Recent findings Over the last decade, several noninvasive devices have undergone development and clinical trials to evaluate efficacy and safety. Based on this body of work, single-pulse transcranial magnetic stimulation, transcutaneous supraorbital neurostimulation, and noninvasive vagal nerve stimulation devices have been cleared by the United States Food and Drug Administration and are available for clinical use for the treatment of primary headache disorders. Summary Overall, these novel noninvasive devices appear to be safe, well tolerated, and have demonstrated promising results in clinical trials in both migraine and cluster headache. This narrative review will provide a summary and update of the proposed mechanisms of action, evidence, safety, and future directions of various currently available modalities of noninvasive neuromodulation for the treatment of migraine and cluster headache.

KW - cluster headache

KW - migraine

KW - neuromodulation

KW - transcranial magnetic stimulation

KW - transcutaneous supraorbital nerve stimulation

KW - vagal nerve stimulation

UR - http://www.scopus.com/inward/record.url?scp=85046754604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046754604&partnerID=8YFLogxK

U2 - 10.1097/WCO.0000000000000557

DO - 10.1097/WCO.0000000000000557

M3 - Review article

C2 - 29601305

AN - SCOPUS:85046754604

VL - 31

SP - 268

EP - 273

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 3

ER -